Notice of meeting.
Pursuant to the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix as amended), the Sunshine in the Government Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.150, and in accordance with section 10(a)(2) of Public Law, a Defense Health Board (DHB) meeting is announced.
February 21, 2012
9 a.m.-12 p.m. (Open Session).
12 p.m.-1 p.m. (Administrative Working Meeting).
1 p.m.-4:30 p.m. (Open Session).
February 22, 2012
8 a.m.-2 p.m. (Administrative Working Meeting).
Marriott Rivercenter, 101 Bowie Street, San Antonio, Texas 78205.
FOR FURTHER INFORMATION CONTACT:
Ms. Christine Bader, Director, Defense Health Board, 5111 Leesburg Pike, Suite 810, Falls Church, Virginia 22041-3206, (703) 681-8448, Ext. 1215, Fax: (703) 681-3317, Christine.email@example.com.
Additional information, including the agenda and electronic registration are available at the DHB Web site, http://www.health.mil/dhb/default.cfm. Anyone intending to attend is encouraged to register to ensure that adequate seating is available.
Purpose of the Meeting
The purpose of the meeting is to address and deliberate pending and new issues before the Board.
On February 21, 2012, the Dover Port Mortuary Independent Review Subcommittee will report its findings to the Board. Additionally, the Board will receive briefings regarding military health needs and priorities from guest speakers and representatives of the Department of Defense.
Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102-3.140 through 102-3.165 and subject to availability of space, the DHB meeting on February 21, 2012 will be open to the public from 9 a.m. to 12 p.m. and 1 p.m. to 4:30 p.m. On February 22, 2012, the Board will be conducting an administrative working session.
Any member of the public wishing to provide comments to the DHB may do so in accordance with 41 CFR 102-3.140(c) and section 10(a)(3) of the Federal Advisory Committee Act, and the procedures described in this notice.
Individuals desiring to provide comments to the DHB may do so by submitting a written statement to the DHB Designated Federal Officer (DFO) (see FOR FURTHER INFORMATION CONTACT). Written statements should address the following details: the issue, discussion, and a recommended course of action. Supporting documentation may also be included, as needed, to establish the appropriate historical context and to provide any necessary background information.
If the written statement is not received at least 10 calendar days prior to the meeting, the DFO may choose to postpone consideration of the statement until the next open meeting.
The DFO will review all timely submissions with the DHB President and ensure they are provided to members of the DHB before the meeting that is subject to this notice. After reviewing the written comments, the DHB President and the DFO may choose to invite the submitter to orally present their issue during an open portion of this meeting or at a future meeting. The DFO, in consultation with the DHB President, may allot time for members of the public to present their issues for review and discussion by the Defense Health Board.
If special accommodations are required to attend (sign language, wheelchair accessibility) please contact Ms. Lisa Jarrett at (703) 681-8448 ext. 1280 by Friday, February 10, 2012.
Dated: January 9, 2012.
Alternate Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2012-518 Filed 1-12-12; 8:45 am]
BILLING CODE 5001-06-P